E3S Web Conf.
Volume 185, 20202020 International Conference on Energy, Environment and Bioengineering (ICEEB 2020)
|Number of page(s)||4|
|Section||Medical Biology and Medical Signal Processing|
|Published online||01 September 2020|
Research on Cervical Cancer and Its Drug Treatment
College of Pharmacy, Tianjin Medical University, 300070, Tianjin, China
Corresponding author: firstname.lastname@example.org
Cervical cancer is one of the common malignant tumors in gynecology, usually due to persistent infection with human papillomavirus (HPV). At present, the main therapeutic drugs used in clinical practice are traditional chemotherapeutic drugs and targeted drugs, and drug therapy mainly includes traditional cytotoxic chemotherapy, targeted therapy, immunotherapy. Because traditional chemotherapeutic drugs usually can not solve the problem of drug resistance and side effects, people started using molecular biology and genomics study of targeted drug therapy. This article mainly discusses the target drug treatment of cervical cancer, anti-angiogenesis, immune checkpoint inhibitor treatment methods, as they have been applied in the treatment of cervical cancer and showed effect, which also brought new hope for the treatment of cervical cancer.
© The Authors, published by EDP Sciences, 2020
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.